IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 698 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease

Scaria P Thomas, Gangadhar Reneega, Pisharody Ramdas

Year : 2009| Volume: 41| Issue : 4 | Page no: 187-191

   This article has been cited by
1 Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis
Lijuan Zhao, An Liu, Guoshuang Xu
Renal Failure. 2021; 43(1): 1378
[Pubmed]  [Google Scholar] [DOI]
2 Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Marinella Ruospo, Suetonia C Palmer, Patrizia Natale, Jonathan C Craig, Mariacristina Vecchio, Grahame J Elder, Giovanni FM Strippoli
Cochrane Database of Systematic Reviews. 2018; 2018(8)
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis
Chun-Juan Zhai,Xiao-Wei Yang,Jing Sun,Rong Wang
International Urology and Nephrology. 2014;
[Pubmed]  [Google Scholar] [DOI]
4 Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis
Stefan Vegter, Keith Tolley, Michael S. Keith, Maarten J. Postma
Value in Health. 2011;
[HTML Full text]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow